Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in migraine treatment.

George R Nissan1, Merle L Diamond

  • 1Diamond Headache Clinic, 467 W Deming Pl, Suite 500, Chicago, IL 60614-2970, USA. gnissan@diamondheadache.com

The Journal of the American Osteopathic Association
|June 2, 2005
PubMed
Summary

Early diagnosis and treatment of migraine, a common neurological disorder, improve quality of life. New research supports early interventions for acute episodes and prophylactic treatments like botulinum toxin for chronic migraine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eptinezumab treatment was associated with longer interictal headache/migraine periods which corresponded to greater improvements in patient-reported quality of life measures.

Journal of neurology·2024
Same author

Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive Treatments.

Journal of clinical medicine·2022
Same author

Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache.

Headache·2021
Same author

Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2.

Headache·2020
Same author

Approach to the Identification and Differentiation of Migraine.

The Journal of family practice·2018
Same author

Migraine disability, healthcare utilization, and expenditures following treatment in a tertiary headache center.

Proceedings (Baylor University. Medical Center)·2013

Area of Science:

  • Neurology
  • Clinical Practice

Background:

  • Migraine is a prevalent and debilitating neurological disorder often underdiagnosed.
  • Accurate diagnosis is crucial for improving patient quality of life.

Purpose of the Study:

  • To highlight the importance of early and correct migraine diagnosis.
  • To discuss current research and treatment approaches for migraine management.

Main Methods:

  • Utilizing screening tools to differentiate migraine from other headache disorders.
  • Investigating central sensitization and cutaneous allodynia in chronic migraine.
  • Evaluating triptans and other agents for acute migraine treatment.
  • Assessing botulinum toxin type A for migraine prophylaxis.

Main Results:

  • Early treatment of acute migraine episodes with triptans yields improved pain-free results within 2 hours.
  • Botulinum toxin type A provides an alternative prophylactic option for patients unresponsive to other treatments.

Conclusions:

  • Prompt diagnosis and targeted treatments significantly enhance patient outcomes in migraine management.
  • Novel therapeutic strategies are expanding options for both acute and prophylactic migraine care.

Related Experiment Videos